GeoVax Labs (GOVX) Revenue Growth (5y) (2015 - 2025)
GeoVax Labs (GOVX) Revenue Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.11% |
| Mar 31, 2025 | 17.98% |
| Dec 31, 2024 | 26.34% |
| Sep 30, 2024 | 52.95% |
| Jun 30, 2024 | 7.45% |
| Mar 31, 2022 | -22.72% |
| Dec 31, 2021 | -1.17% |
| Sep 30, 2021 | -41.40% |
| Jun 30, 2021 | -13.68% |
| Mar 31, 2021 | 18.33% |
| Dec 31, 2020 | 9.47% |
| Sep 30, 2020 | 34.86% |
| Jun 30, 2020 | 43.87% |
| Mar 31, 2020 | 47.25% |
| Dec 31, 2019 | 3.78% |
| Sep 30, 2019 | 0.68% |
| Jun 30, 2019 | 3.07% |
| Mar 31, 2019 | 18.28% |
| Dec 31, 2018 | 11.36% |
| Sep 30, 2018 | -19.04% |